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Abstract
Background: We investigated how body size and physical activity influence the risk of the CpG island methylator phenotype
(CIMP) in colorectal cancer (CRC).
Methods: In the Netherlands Cohort Study (n=120,852), risk factors were self-reported at baseline in 1986. After 7.3 years of
follow-up, 603 cases and 4,631 sub-cohort members were available. CIMP status according to the Weisenberger markers
was determined using methylation specific PCR on DNA from paraffin embedded tumor tissue. Hazard rate ratios (HR) and
95% confidence intervals for CIMP (27.7%) and non-CIMP (72.3%) tumors were calculated according to BMI, BMI at age 20,
BMI change, trouser/skirt size, height, and physical activity.
Results: BMI modeled per 5 kg/m
2 increase was associated with both CIMP and non-CIMP tumors, however, HRs were
attenuated when additionally adjusted for trouser/skirt size. Trouser/skirt size, per 2 size increase, was associated with both
tumor subtypes, even after adjustment for BMI (CIMP HR: 1.20, 95%CI: 1.01–1.43; non-CIMP HR: 1.14, 95%CI: 1.04–1.28).
Height per 5 cm was associated with both tumor sub-types, but HRs were attenuated when adjusted for body weight. BMI
at age 20 was positively associated with increased risk of CIMP tumors and the association was significantly less pronounced
for non-CIMP tumors (P-heterogeneity=0.01). Physical activity was inversely associated with both subtypes, but a dose-
response association was observed only for non-CIMP tumors (P-trend=0.02).
Conclusions: Body size, especially central adiposity, may increase the risk of both CIMP and non-CIMP tumors. Body fat at
young age may differentially influence risk. Physical activity appears to decrease the risk of CRC regardless of these
molecular subtypes.
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Introduction
It is well accepted that indicators of energy balance influence
the risk of colorectal cancer (CRC). A high body mass index
(BMI), waist circumference, and adult attained height are clear risk
factors for CRC, while physical activity has been shown to be
protective [1]. Although CRC is one of the best described cancers
in terms of genetic and epigenetic events involved [2–5], little is
known about how measures of anthropometry and physical
activity are associated with different molecular subsets of this
disease. Elucidating potential differences in risk between molecular
subtypes of CRC may lead to a better understanding of CRC,
treatment, and prevention. This is especially important as the
global prevalence of overweight and obesity continues to rise.
A distinct characteristic of epigenetic instability in CRC is the
CpG island methylator phenotype (CIMP), characterized by
numerous promoter CpG island hypermethylated tumor suppres-
sor- and DNA repair genes [6–9]. This in turn is associated with
transcriptional silencing of gene expression [10]. Few studies have
investigated associations between indicators of energy balance and
CIMP status, and those that have, only considered BMI as an
indicator of body size. In a case-control setting, Slattery et al.
reported an association between a high BMI and CIMP low but not
CIMP high colon tumors [11], and no association between BMI
and CIMP status in rectal tumors [12]. Vigorous physical activity
was associated with both CIMP high and CIMP low colon tumors,
but not rectal tumors [11,12]. It has been hypothesized that DNA
methylation is a consequence of inflammation [13,14]. Central
adiposity is also associated with chronic inflammation [15].
Therefore, considering waist circumference as a risk factor for
CIMP in addition to BMI is important. Additionally, methylation is
thought to be an early event in CRC[16], so considering heightand
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indicative of in utero and early life exposures [17].
Using the prospective Netherlands Cohort Study on diet and
cancer (NLCS), we investigated the association between BMI,
clothing size (as a proxy for waist circumference) and physical
activity and risk of developing a tumor characterized by CIMP.
Furthermore, in attempt to elucidate if timing of exposure is
important for modulating this risk, we also investigated associations
accordingtoBMIatage20,BMIchange,and adult-attainedheight.
Results
Baseline and molecular characteristics are described in Table 1.
Proportionally,CIMPCRCcasesweremorelikelytobefemale,have
a tumor in the proximal colon, and be older than non-CIMP cases.
Associations between measures of anthropometry, physical
activity and CRC risk according to CIMP status are shown in
Table 2. After adjustment for age and sex, BMI modeled per
5 kg/m
2 increase was statistically significantly associated with
CIMP tumors (HR: 1.29, 95% CI: 1.01–1.66), and a statistically
significant dose-response relationship was observed when model-
ing quartiles of BMI (P-trend=0.02). However, when models were
mutually adjusted for trouser/skirt size, these associations were
greatly attenuated. BMI was also positively, though not statistically
significantly, associated with non-CIMP tumors. These were also
attenuated when mutually adjusted for trouser/skirt size. The HRs
for CIMP and non-CIMP tumors did not differ significantly from
one another (P-heterogeneity=0.78). BMI at age 20 modeled per
5 kg/m
2 increase was associated with increased risk of both
subtypes, but HRs did not reach statistical significance. When
Table 1. Characteristics of NLCS study participants according to colorectal cancer status after 7.3 years of follow-up.
MEN WOMEN
Sub-cohort
* CIMP+ Non-CIMP Sub-cohort CIMP+ Non-CIMP
Baseline characteristics
Total (% of cases) 2219 83 (25) 245 (75) 2390 81 (30) 190 (70)
Age (years)
{ 61.3 (4.2) 63.0 (4.1) 62.8 (4.1) 61.5 (4.3) 63.3 (4.0) 62.8 (4.0)
Height (cm) 176.4 (6.7) 176.5 (6.7) 176.9 (6.6) 165.1 (6.2) 166.5 (6.2) 166.2 (6.3)
BMI (kg/m
2) 25.0 (2.6) 25.8 (2.6) 25.3 (2.9) 25.1 (3.6) 25.4 (2.9) 25.6 (3.5)
BMI (kg/m
2) at age 20 21.8 (2.4) 22.4 (2.5) 21.8 (2.2) 21.4 (2.8) 21.5 (2.2) 21.6 (2.6)
BMI change
Clothing size 51 (4) 52 (6) 52 (3) 44 (3) 44(3) 44(3)
Recreational physical activity (%)
,30 min/day 19 21 13 27 33 31
30–60 min/day 31 30 32 31 23 32
60–90 min/day 18 20 18 22 18 22
.90 min/day 31 29 37 21 28 15
Occupational physical activity (%)
,8 kj/min 57 72 63 58 52 51
8–12 kj/min 27 18 22 36 40 40
.12 kj/min 16 11 15 6 8 10
Sports participation during youth (%)
N e v e r 5 05 24 9 6 2 7 3 6 2
Only after puberty 23 24 20 20 15 22
Before, during, and after puberty 27 24 31 19 12 16
Molecular characteristics
Site (%)
Proximal colon - 54 20 - 67 25
Distal colon - 24 39 - 18 37
Rectosigmoid - 5 11 - 4 17
Rectum - 17 30 - 11 22
MSI status (%)
Stable - 72 95 - 60 97
Unstable - 28 5 - 40 3
BRAF V600E mutation status
Wildtype - 64 94 - 54 93
Mutated - 36 6 - 46 7
*from subcohort of 5000 individuals selected randomly at baseline.
{mean (sd) or percentages where indicated.
doi:10.1371/journal.pone.0018571.t001
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of anthropometry in the NLCS after 7.3 years of follow-up.
CIMP + Non-CIMP
PY N HR (95%CI)
* HR (95%CI)
{ HR (95%CI)
{ N HR (95%CI)
* HR (95%CI)
{ HR (95%CI)
{ P-heterogeneity
1
BMI at baseline
Per 5 kg/m
2 24,272 117 1.29 (1.01–1.66) 1.25 (0.96–1.64) 1.04 (0.73–1.49) 318 1.19 (0.98–1.14) 1.19 (0.98–1.14) 1.08 (0.85–1.38)
Quartiles
1 8080 29 1 (referent) 1 (referent) 1 (referent) 92 1 (referent) 1 (referent) 1 (referent)
2 4491 20 1.28 (0.71–2.30) 1.22 (0.67–2.23) 1.11 (0.62–2.00) 57 1.01 (0.71–1.45) 1.00 (0.69–1.43) 0.97 (0.67–1.40)
3 7901 44 1.52 (0.94–2.44) 1.45 (0.90–2.35) 1.22 (0.73–2.04) 109 1.19 (0.89–1.59) 1.18 (0.88–1.59) 1.09 (0.79–1.50)
4 3799 24 1.85 (1.07–3.21) 1.77 (1.01–3.11) 1.45 (0.90–2.35) 60 1.22 (0.86–1.75) 1.22 (0.84–1.75) 1.03 (0.69–1.54)
P-trend 0.02 0.03 0.32 0.15 0.18 0.71
0.78
BMI @ 20
Per 5 kg/m
2 24,272 117 1.28 (0.96–1.72) 1.28 (0.96–1.72) 1.22 (0.90–1.65) 318 1.14 (0.92–1.39) 1.10 (0.90–1.34) 1.17 (0.94–1.44)
Quartiles
1 6112 21 1 (referent) 1 (referent) 1 (referent) 76 1 (referent) 1 (referent) 1 (referent)
2 6139 24 1.17 (0.64–2.11) 1.23 (0.67–2.26) 1.16 (0.64–2.11) 91 1.20 (0.87–1.66) 1.21 (0.87–1.66) 1.24 (0.89–1.72)
3 6070 42 2.01 (1.18–3.43) 2.09 (1.22–3.59) 1.94 (1.14–3.32) 74 0.99 (0.71–1.38) 0.98 (0.70–1.37) 1.02 (0.72–1.43)
4 5951 30 1.53 (0.87–2.70) 1.57 (0.88–2.82) 1.43 (0.81–2.55) 77 1.08 (0.78–1.51) 1.04 (0.75–1.45) 1.12 (0.80–1.57)
P-trend 0.03 0.03 0.07 0.95 0.81 0.8
0.01
BMI change
,0 2896 10 0.61 (0.31–1.21) 0.63 (0.32–1.24) 0.52 (0.25–1.07) 28 0.72 (0.47–1.10) 0.74 (0.48–1.13) 0.65 (0.42–1.02)
0–3.9 11,594 62 1 (referent) 1 (referent) 1 (referent) 158 1 (referent 1 (referent) 1 (referent)
4–7.9 7709 34 0.77 (0.51–1.18) 0.74 (0.45–1.13) 0.89 (0.55–1.28) 102 0.94 (0.72–1.22) 0.94 (0.72–1.23) 1.00 (0.76–1.31)
$8.0 2073 11 0.93 (0.48–1.79) 0.86 (0.44–1.68) 1.06 (0.55–2.05) 30 1.11 (0.73–1.68) 1.08 (0.70–1.66) 1.23 (0.79–1.89)
P-trend 0.89 0.86 0.37 0.28 0.37 0.09
0.93
Trouser/skirt
size at baseline
Per 2 sizes 24,272 117 1.20 (1.06–1.35) 1.20 (1.05–1.37) 1.20 (1.01–1.43) 318 1.14 (1.05–1.24) 1.14 (1.05–1.24) 1.15 (1.04–1.28)
Quartiles
1 9561 31 1 (referent) 1 (referent) 1 (referent) 104 1 (referent) 1 (referent) 1 (referent)
2 7805 43 1.65 (1.03–2.64) 1.66 (1.05–2.69) 1.62 (0.99–2.65) 109 1.16 (0.84–1.61) 1.17 (0.88–1.56) 1.14 (0.85–1.54)
3 4440 26 1.66 (0.98–2.83) 1.66 (0.97–2.85) 1.61 (0.87–2.97) 60 1.19 (0.86–1.65) 1.12 (0.80–1.58) 1.07 (0.74–1.54)
4 2465 17 2.01 (1.10–3.67) 2.01 (1.07–3.77) 1.90 (0.86–4.17) 45 1.46 (1.04–2.04) 1.53 (1.04–2.24) 1.39 (0.87–2.23)
P-trend 0.01 0.02 0.10 0.002 0.06 0.28
0.61
Height at
baseline
Per 5 cm 24,272 117 1.14 (1.00–1.30) 1.16 (1.01–1.33) 1.05 (0.91–1.22) 318 1.11 (1.01–1.21) 1.10 (1.00–1.21) 1.05 (0.95–1.17)
Quartiles
1 6589 28 1 (referent) 1 (referent) 1 (referent) 75 1 (referent) 1 (referent) 1 (referent)
2 6294 31 1.17 (0.70–1.98) 1.19 (0.71–2.01) 1.06 (0.63–1.80) 81 1.16 (0.84–1.61) 1.16 (0.83–1.62) 1.10 (0.79–1.53)
3 6612 32 1.18 (0.70–1.38) 1.19 (0.71–2.01) 0.99 (0.58–1.68) 85 1.19 (0.86–1.65) 1.13 (0.80–1.57) 1.08 (0.77–1.51)
4 4777 26 1.38 (0.79–2.38) 1.47 (0.82–2.61) 1.05 (0.58–1.89) 77 1.46 (1.04–2.04) 1.45 (1.03–2.06) 1.24 (0.86–1.79)
P-trend 0.28 0.23 0.96 0.04 0.06 0.31
0.98
*models adjusted for age and sex.
{models adjusted for age, sex, and additionally for family history of CRC (yes/no), smoking status (never smoker, ex-smoker, current smoker), socioeconomic status (level
of education: primary school, junior high school, senior high school, higher vocational school, or university), total energy intake (kcal/day), alcohol intake (0, 0.1–4, 5–
14, 15–29, $30 g/day), and consumption of red meat, fruit, vegetables, and grains (g/day). Models with anthropometric variables were additionally adjusted for
baseline physical activity (based on recreational physical activity for women (low#30 minutes/day, intermediate=30–90 minutes/day, high$90 minutes/day) and
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trend was observed for CIMP tumors (P=0.03). This trend
became borderline significant when the model was adjusted for
trouser/skirt size (P-trend =0.07). The test for heterogeneity
between tumor subtypes was statistically significant with respect to
BMI at age 20, even after adjustment for trouser/skirt size (P-
heterogeneity=0.01). No statistically significant observations were
observed with respect to BMI change.
Trouser/skirt size, modeled per 2 unit size increase, was
associated with both CIMP (HR: 1.20, 95%CI: 1.05–1.37) and
non-CIMP tumors (HR: 1.14, 95% CI: 1.05–1.24) after
multivariate adjustment, and these associations remained even
when models were mutually adjusted for BMI. When trouser/skirt
size was considered in approximate quartiles, the test for trend was
significant for CIMP (p=0.02) and borderline significant for non-
CIMP (P=0.06) tumors, although these were attenuated when
models were mutually adjusted for BMI. Associations observed for
CIMP and non-CIMP tumors were not statistically significantly
different from each other (P-heterogeneity=0.61).
Height, modeled per 5 cm increase was associated with both
CIMP (HR: 1.16, 95% CI: 1.01–1.33) and non-CIMP (HR: 1.10,
95% CI: 1.00–1.21) tumors after multivariate adjustment. A
borderline statistically significant trend was observed for risk of
non-CIMP tumors when height was considered in quartiles
(highest versus lowest quartile HR: 1.45, 95% CI: 1.03–2.06;
P=0.06) (p-heterogeneity=0.98). These associations were atten-
uated when the model was mutually adjusted for body weight.
With low physical activity as the reference category, there was
no inverse dose-response association between physical activity and
CIMP tumors, although the HR for intermediate physical activity
was statistically significant (HR: 0.50, 95%CI: 0.30–0.82)
(Table 3). An inverse association was observed in a dose-response
fashion for non-CIMP tumors (intermediate physical activity HR:
0.80, 95%CI: 0.61–1.04; high physical activity HR: 0.69, 95%CI:
0.47–0.96; P-trend=0.02), however, associations with CIMP and
non-CIMP tumors did not differ significantly from each other (P-
heterogeneity=0.33).
Associations for a tumor methylation index in relation to
anthropometric risk factors and physical activity are shown in
Table 4. There was no clear pattern with respect to the degree of
methylation, however, when modeled per 2 unit size increase,
trouser/skirt size was associated in a dose-response manner with
tumors displaying the highest level of methylation (4–7 genes
methylated HR: 1.29, 95%CI: 1.06–1.58; P-trend=0.08).
Discussion
These data suggest that adult body fatness and height may
increase the risk of CRC, but are not differentially associated with
CIMP and non-CIMP tumors. Contrarily, BMI at age 20 may be
a stronger risk factor for CIMP+ tumors. Baseline physical activity
appears to decrease the risk of CRC regardless of CIMP status.
A major strength of this study is that we investigated
associations in a prospective cohort setting. The NLCS has
almost complete ascertainment of colorectal cancer and very little
loss to follow-up. Although the number of total CRC after 7.3
years of follow-up in the NLCS was substantial, the number of
cases with the CIMP phenotype was small. With limited power to
detect associations, it is possible that some findings arose by
chance. Another potential limitation of this study is that
anthropometric variables were obtained by self-report. However,
there are many examples in the literature showing that this
method is a valid and reliable tool for assessing body weight and
height in cohort studies [18–21].
To our knowledge, associations between indicators of energy
balance and CIMP status of colorectal tumors have been reported
Table 3. Hazard Ratios (HR) and 95% Confidence Intervals (CI) for colorectal cancer characterized by CIMP, according to physical
activity status in the NLCS after 7.3 years of follow-up.
CIMP + Non-CIMP
PY N HR (95%CI)
* HR (95%CI)
{ N HR (95%CI)
* HR (95%CI)
{ P-heterogeneity
1
Physical activity
||
Low 9468 58 1 (referent) 1 (referent) 162 1 (referent) 1 (referent)
Intermediate 9312 29 0.50 (0.30–0.82) 0.50 (0.30–0.81) 115 0.80 (0.61–1.04) 0.81 (0.61–1.07)
High 4252 21 0.82 (0.49–1.38) 0.81 (0.48–1.36) 44 0.67 (0.47–0.96) 0.69 (0.47–1.01)
P-trend 0.22 0.22 0.02 0.04
0.33
*models adjusted for age and sex.
{models adjusted for age, sex, and additionally for trouser/skirt size, family history of CRC (yes/no), smoking status (never smoker, ex-smoker, current smoker),
socioeconomic status (level of education: primary school, junior high school, senior high school, higher vocational school, or university), total energy intake (kcal/day),
alcohol intake (0, 0.1–4, 5–14, 15–29, $30 g/day), and consumption of red meat, fruit, vegetables, and grains (g/day).
1P value for test that HR for two tumor subtypes are equal.
||Physical activity variable is based on baseline non-occupational physical activity for females, and occupational physical activity in males, as described in the methods.
doi:10.1371/journal.pone.0018571.t003
occupational physical activity at the longest held job for men (low#8 kj/minute, intermediate =8–12 kj/minute, and high$12 kj/minute).
{Models adjusted for age and sex, and mutually adjusted for other anthropometric variables. Models with BMI and BMI at age 20 were additionally adjusted for trouser/
skirt size; the model for BMI change was additionally adjusted for BMI at age 20; the model with trouser/skirt size was additionally adjusted for BMI; the model with
height was additionally adjusted for body weight.
1P value for test that HR for two tumor subtypes are equal (based on model 3).
doi:10.1371/journal.pone.0018571.t002
Table 2. Cont.
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{ according to anthropometric risk factors
and physical activity in the NLCS 7.3 years of follow-up.
0–1 genes methylated 2–3 genes methylated 4–7 genes methylated
PY N HR (95% CI) N HR (95% CI) N HR (95% CI)
BMI at baseline
Per 5 kg/m
2 24,272 116 1.07 (0.74–1.54) 154 1.05 (0.75–1.48) 100 1.02 (0.67–1.56)
Quartiles
1 8080 44 1 (referent) 42 1 (referent) 24 1 (referent)
2 4491 12 0.48 (0.24–0.97) 31 1.15 (0.70–1.90) 20 1.33 (0.71–2.50)
3 7901 40 0.85 (0.52–1.39) 50 1.20 (0.75–1.91) 37 1.15 (0.63–2.10)
4 3799 20 0.71 (0.38–1.33) 31 1.37 (0.79–2.39) 19 1.19 (0.52–2.70)
P-trend 0.43 0.28 0.75
BMI @ 20
Per 5 kg/m
2 24,272 116 1.28 (0.95–1.73) 154 1.23 (0.93–1.63) 100 1.06 (0.75–1.49)
Quartiles
1 6112 23 1 (referent) 37 1 (referent) 20 1 (referent)
2 6139 40 1.81 (1.07–3.06) 34 0.91 (0.56–1.46) 20 1.02 (0.54–1.92)
3 6070 24 1.07 (0.59–1.91) 39 1.06 (0.67–1.67) 38 1.84 (1.06–3.19)
4 5951 29 1.31 (0.75–2.29) 44 1.24 (0.80–1.94) 22 1.09 (0.59–2.03)
P-trend 0.82 0.28 0.31
BMI change
,0k g / m
2 6115 9 0.54 (0.25–1.15) 15 0.70 (0.39–1.28) 8 0.58 (0.26–1.28)
0–3.9 5973 59 1 (referent) 88 1 (referent) 52 1 (referent)
4–7.9 6100 39 1.05 (0.68–1.63) 39 0.70 (0.47–1.03) 28 0.81 (0.51–1.29)
$8.0 6085 9 0.99 (0.47–2.08) 12 0.91 (0.49–1.72) 12 1.34 (0.69–2.57)
0.28 0.63 0.35
Trouser size at baseline
Per 2 sizes 24,272 116 1.13 (0.96–1.34) 154 1.12 (0.97–1.29) 100 1.29 (1.06–1.58)
Quartiles
1 9561 48 1 (referent) 55 1 (referent) 28 1 (referent)
2 7805 26 0.68 (0.40–1.14) 56 1.25 (0.84–1.87) 33 1.52 (0.86–2.68)
3 4440 25 1.06 (0.62–1.81) 24 0.90 (0.52–1.56) 24 1.79 (0.88–3.64)
4 2465 17 1.24 (0.59–2.58) 19 1.22 (0.63–2.38) 15 2.00 (0.83–4.80)
P-trend 0.56 0.87 0.08
Height at baseline
Per 5 cm 24,272 116 1.04 (0.89–1.22) 154 1.11 (0.96–1.28) 100 1.07 (0.92–1.24)
Quartiles
1 6589 30 1 (referent) 36 1 (referent) 19 1 (referent)
2 6294 26 0.89 (0.52–1.51) 38 1.09 (0.68–1.74) 32 1.61 (0.91–2.88)
3 6612 33 1.06 (0.63–1.80) 41 1.11 (0.70–1.78) 27 1.23 (0.67–2.26)
4 4777 27 1.17 (0.65–2.11) 39 1.34 (0.80–2.25) 22 1.31 (0.67–2.55)
P-trend 0.52 0.30 0.68
Physical activity
{
Low 9468 56 1 (referent) 81 1 (referent) 47 1 (referent)
Intermediate 9312 48 0.85 (0.55–1.31) 56 0.82 (0.57–1.18) 28 0.60 (0.37–1.02)
High 4252 18 0.72 (0.41–1.28) 17 0.54 (0.31–0.94) 18 0.88 (0.50–1.54)
p-trend 0.25 0.02 0.42
*All models were adjusted for age and sex. Models with BMI and BMI at age 20 were additionally adjusted for trouser/skirt size, models with BMI change were
additionally adjusted for BMI at ahe 20, models with trouser/skirt size were additionally adjusted for BMI, and models with height were additionally adjusted for body
weight.
{methylation index including the five CIMP markers (CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1), MLH1, and the APC gene.
{Based on baseline non-occupational physical activity for women (low#30 minutes/day, intermediate=30–90 minutes/day, high$90 minutes/day) and occupational
physical activity at the longest held job for men (low#8 kj/minute, intermediate =8–12 kj/minute, and high$12 kj/minute).
doi:10.1371/journal.pone.0018571.t004
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to the study design, there are differences between our studies
which should be taken into account when comparing results.
The NLCS utilized the Weisenberger panel of genes to define
CIMP (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1),
whereas the study of Slattery et al., utilized the Classic panel
(MINT1, MINT2, MINT31, p16 and hMLH1), as well as different
cut-offs to define CIMP in tumors [22,23]. The ‘right’ definition of
CIMP is still a highly debated topic, as is the ideal gene panel and
the appropriate method of methylation detection [12,24]. While
the Weisenberger panel has been validated, different markers of
methylation may be more or less informative with respect to
studying different exposures. The prevalence of CIMP in the
NLCS population is higher than in the study by Slattery et al. (27%
vs. 11%) [12]. However, a difference in primer designs and PCR
conditions may substantially change sensitivity and specificity of a
particular marker for the detection of CIMP in CRC [25].
Therefore, it is likely that differences in prevalence are not due to
the different methods per se, but rather a difference in choice of
primers. The MSP analyses that have been conducted in the
NLCS have a high detection signal, and subsequently, a higher
prevalence of CIMP has been observed. In the present study, we
attempted to clarify our observations by constructing a methyla-
tion index with different cut-off points that included seven genes
commonly methylated in CRC.
In the present study we considered colon and rectal tumors
together to increase statistical power. A sensitivity analysis revealed
that this did not bias our findings (data not shown). Furthermore,
we suggest that idea of combining sub-localizations of tumors may
be acceptable when studying molecular endpoints, because this
may help explain differences in etiology according to sub-
localization.
We observed that BMI was associated with both tumor CIMP
and non-CIMP tumors; however, after adjustment for clothing
size, these associations disappeared. This is in contrast to case-
cohort data suggesting that BMI is associated only with CIMP
negative colon tumors and not with rectal tumors [11,12]. In our
study, trouser/skirt size appears to be a strong, independent
predictor of both tumor subtypes, even after adjustment for BMI.
This is logical, because waist circumference, an indicator of central
adiposity, is a stronger predictor of CRC than BMI [1,26]. When
we considered associations according to a methylation index, we
did not observe clear associations with respect to BMI and degree
of promoter methylation, however, we did observed that trouser/
skirt size was associated with the highest level of methylation. That
we observed associations between trouser/skirt size and both
CIMP and non-CIMP tumors suggests that central adiposity may
influence CRC risk through both a methylation and a non-
methylation pathway.
Although very few studies have considered associations between
BMI and CIMP, a number have considered endpoints in the same
pathway as CIMP. Colorectal cancer has distinct molecular
subsets, which evolve through different pathways [16]. The path to
a serrated adenocarcinoma appears to take one of two major
routes: the traditional serrated pathway or the sessile serrated
pathway [27]. The sessile serrated pathway is characterized by a
high degree of CIMP, BRAF V600E mutations, and ultimately
develops into microsatellite instability (MSI) [27]. MSI may serve
as a marker for CIMP or other molecular events in CRC [28],
therefore, it may be informative to consider the findings of the
present study in the context of that research. Two case-control
studies have reported that BMI appears associated with microsat-
ellite stable (MSS) tumors, and less with MSI tumors [29,30].
Neither study reported associations according to waist circumfer-
ence. In a recent pooled analysis of NLCS and data from the
Melbourne Collaborative Cohort Study, we observed similar
associations, although the test for heterogeneity between the tumor
subtypes was not statistically significant (Hughes et al., submitted).
There is evidence to suggest that early life exposures influence
epigenetic mechanisms associated with adult disease risk [31,32].
Therefore, we also investigated associations between BMI at age
20, BMI change, height and CIMP status. Height is a marker of an
aggregated fetal and childhood experience, and can be considered
a proxy measure for important nutritional exposures, which affect
several hormonal and metabolic axes [17]. In the NLCS, we have
observed that childhood and adolescent energy restriction is
associated with a decreased risk of CRC later in life [33,34], which
is supported by other population based studies [35–37]. We also
recently reported that exposure to severe energy restriction during
childhood and adolescence was associated with a low risk of
developing a CIMP tumor [32]. Furthermore, pooled data suggest
that taller individuals are at greater risk of developing a MSI
tumor (Hughes et al. submitted). According to the present study,
height is not differentially associated with the risk of tumors,
however, we did observe significant heterogeneity with respect to
BMI at age 20 and tumor subtypes. Taken together, our findings
suggest that body size may differentially influence CIMP status
during different periods of life, potentially affecting later CRC risk.
The association between BMI at age 20 and CIMP tumors was
stronger than with non-CIMP tumors, which is in line with
previous findings for severe energy restriction during childhood
and adolescence. Although our bootstrapping method is quite
conservative, we did not observe a clear association with respect to
BMI at age 20 and the methylation index and therefore we can not
rule out that the differential association with CIMP status is a
chance finding. The hypothesis that timing of exposure may
influence epigenetic mechanisms requires further investigation.
That we did not observe any clear associations between BMI
change and risk of tumors was surprising. This may indicate that
metabolic changes in fat may be more important for modulating
risk over time, rather than BMI. Alternatively, considering men
and women together may have attenuated these observations.
Campbell et al. report that adult weight gain was associated with
CRC in men, but not in women, and only with respect to
individuals who gained more than 21 kg since age 20 [29]. Finally,
only considering two time points may not be indicative of true
BMI change.
Our findings with respect to physical activity support those of
Slattery et al. [11], and suggest that high levels of daily exercise are
associated with a decreased risk of both CIMP and non-CIMP
tumors. Observations with respect to our methylation index
suggest that physical activity may be more protective of tumors
with increasing methylation, but more research is required before
firm conclusions can be drawn.
Preliminary evidence suggests that molecular markers can be
used to classify colorectal cancers into distinct subtypes, which
have implications for both etiology and prevention [28]. Fewer
tumors arise from the sessile serrated pathway compared to the
traditional adenoma pathway [27,38]. As overweight and obesity
are such strong risk factors for CRC, there is a possibility that these
conditions may differentially influence risk through pathways and
molecular mechanisms other than what we investigated here.
More research is needed to clarify the association between
indicators of energy balance and epigenetic mechanisms leading
to CRC; preferably in a prospective cohort setting, with many
cases [39]. Furthermore, as the field of molecular pathological
epidemiology [40] continues to evolve, standardizing methods and
definitions of molecular endpoints should be addressed. This will
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arise.
In conclusion, our findings suggest that measures of anthro-
pometry reflecting a large body size increase the risk of both CIMP
and non-CIMP tumors, and that body fat at young age may
differentially influence risk. Physical activity appears to decrease
the risk of CRC regardless of these molecular subtypes. Our
observations reiterate the importance of a healthy body weight
with respect to general CRC prevention.
Materials and Methods
Study populations and design
The NLCS is a prospective cohort study that was initiated in
1986 to investigate the association between diet and the
development of cancer. It includes 58,279 men and 62,573
women between the ages of 55–69 years at baseline who
completed a self-administered food frequency questionnaire
involving 150 food items as well as questions on dietary habits,
lifestyle, health, and demographics. Municipal registries from
throughout the Netherlands were used to constitute an efficient
sampling frame. The NLCS uses a case – cohort approach for
data processing and analysis; case subjects were derived from the
entire cohort, and the number of person-years at risk for the
entire cohort was estimated from a sub cohort of 5000 men and
women who were randomly sampled from the full cohort at
baseline. All sub cohort members who reported prevalent cancer
(excluding skin cancer) at baseline were excluded from analyses,
leaving 4654. Further details of the NLCS design have been
described [41–43].
Incident CRC cases were identified by annual record linkage to
nine regional cancer registries and a national pathology database
(PALGA) [44]. The completeness of cancer follow-up is almost
100% [45]. Paraffin embedded tumor material from CRC patients
was retrieved, as described previously [46]. In total, 734 incident
CRC patients were identified from a follow-up period of 7.3 years
after baseline, excluding the first 2 years of follow-up, of whom a
PALGA report of the lesion as well as sufficient DNA was available
[46].
The study protocol was approved by the Medical Ethics
Committees of the University Hospital Maastricht and TNO
Nutrition. On recruitment, participants were informed in writing
of the details of the study and its objectives. In accordance with the
regulations at that time, written informed consent was obtained
when participants returned the completed baseline questionnaire.
Tumor material was collected after approval by the ethical review
boards of Maastricht University, the National Cancer Registry,
and PALGA.
Ascertainment of risk factors
Anthropometric variables. Height (cm), body weight (kg),
and body weight at age 20 (kg) were self-reported on the baseline
questionnaire. From these variables, BMI and BMI at age 20, and
BMI change were subsequently calculated. At baseline, individuals
were also asked to report their lower body (trouser or skirt)
clothing size from their clothing label (Dutch sizes). Trouser/skirt
size has been shown to be an adequate proxy measure for waist
circumference when predicting cancer risk in the NLCS, and
details of how clothing size corresponds to waist measurements in
men and women in this Dutch population has been published
[47]. BMI, BMI at age 20, skirt/trouser size, and height were
categorized into approximate sex-specific quartiles. As in previous
NLCS analyses, BMI change was categorized as: ,0 kg/m
2,0 –
4 kg/m
2, 4–8 kg/m
2, and .8 kg/m
2 [48].
Physical activity. With respect to physical activity and CRC
risk in the NLCS population, occupational physical activity
appears to be more important for men and recreational physical
activity for women for predicting risk (Simons et al., submitted).
Therefore, we used these two variables to create sex-specific
categories of ‘low,’ ‘intermediate’ and ‘high’ physical activity.
Occupational physical activity was derived from data on
participants’ occupational history. Using information on the type
of job and the duration, energy expenditure and sitting time was
calculated for the longest and last held job. Energy expenditure
was based on a rating system developed by Hettinger et al. [49] and
distinguishes between work of low, moderate and high activity
which corresponds to an energy expenditure of ,8, 8–12 and
.12 kJ/min. Men were categorized into the ‘low’ category if their
occupational physical activity was ,8 kj/minute, ‘intermediate’ if
they fell into the 8–12 kJ/minute category, and high if their
occupational physical activity was .12 kJ/minute.
Baseline non-occupational physical activity was calculated based
on two questions. The first (open-ended) question was ‘How many
minutes do you spend on average per day walking or cycling to
your work, to go shopping or to take out your dog?’ The reported
time spent per day was categorized into #10, .10–30, .30–60
and .60 minutes per day. The second question was ‘How many
hours of your leisure time do you spend on average per week on 1)
recreational cycling, walking, 2) gardening/doing odd jobs and 3)
sports, gymnastics?’ Answering possibilities were never, ,1 hour
per week, 1–2 hours per week and .2 hours per week. The time
spent on these activities and the minutes spent per day on walking
or cycling to work, to go shopping or to take out the dog were
summed to obtain an overall measure of baseline non-occupa-
tional physical activity, with categories ,30, .30–60, .60–90
and .90 minutes per day. Low physical activity was defined as
,30 minutes/day, intermediate as 30–90 minutes/day, and high
as .90 minutes/day.
Promoter Methylation Analyses
CIMP in tumor tissue of CRC cases was defined by CpG island
promoter hypermethylation of at least 3 out of 5 methylation
markers (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1), as
proposed by Weisenberger et al. [9] were determined by bisulfite
modification of 500 ng genomic DNA using a commercially
available kit (Zymo Research), and subsequent methylation
specific PCR (MSP) [50,51]. We chose to use MSP as a method
because it is effective, specific and does not require specific
equipment. It has been shown that results from MSP are in
accordance with other technologies, such as MethyLight [52].
Additionally, the methylation status of two other genes, APC and
MLH1, were determined and we added them to the CIMP
markers to create a methylation index of seven genes.
To facilitate MSP analysis on DNA retrieved from formalin-
fixed, paraffin-embedded tissue, DNA was first amplified with
flanking PCR primers that amplify bisulfite-modified DNA but do
not preferentially amplify methylated or unmethylated DNA. The
resulting fragment was used as a template for the MSP reaction.
All PCRs were carried out with controls for unmethylated alleles
(DNA from normal lymphocytes), methylated alleles [normal
lymphocyte DNA treated in vitro with SssI methyltransferase (New
England Biolabs, Ipswich, MA)] and a control without DNA. Ten
microliters of each MSP reaction was directly loaded on to
nondenaturing 6% polyacrylamide gels stained with ethidium
bromide and visualised under UV illumination. The MSP analyses
were successful for 81%, 79%, 79%, 90%, 83%, 93%, and 93%
out of the 734 cases for CACNA1G, IGF2, NEUROG1, RUNX3,
SOCS1, MLH1, and APC respectively.
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Data were analyzed with Stata (version 10, Statacorp, College
Station, TX, USA). Cox proportional hazards analysis using the
case-cohort approach was used to obtain hazard ratios (HR) and
95% confidence intervals (CI) for the association between
measures of anthropometry and physical activity and CRC
characterized by CIMP status. To improve statistical power, we
considered men and women together. Tests for effect modification
by sex were not statistically significant. The proportional hazards
assumption was tested using the scaled Schoenfeld residuals and
visual inspection of the hazard curves. To account for the
additional variance introduced by sampling the subcohort from
the entire cohort, standard errors were estimated using the robust
option. Statistical significance was tested at the 0.05 level.
For all anthropometric variables in question, three models were
considered. The first was adjusted only for age and sex. The second
was additionally adjusted for variables identified as being associated
with both CRC and energy balance from previous literature. These
included family history of CRC (yes/no), smoking status (never
smoker, ex-smoker, current smoker), socioeconomic status (level of
education: primary school, junior high school, senior high school,
higher vocational school, or university), total energy intake (kcal/
day), alcohol intake (0, 0.1–4, 5–14, 15–29, $30 g/day), physical
activity (low, medium, high as previously described), and consump-
tion of red meat, fruit, vegetables, and grains (g/day). Finally,
models were mutually adjusted for other anthropometric variables.
Models including BMI and BMI at age 20 were mutually adjusted
for skirt/trouser size, BMI change was adjusted for BMI at age 20,
trouser/skirt size was adjusted for BMI, and height was adjusted for
body weight.
We modeled physical activity adjusted for age and sex, and
additionally adjusted for trouser/skirt size, family history of CRC
(yes/no), smoking status (never smoker, ex-smoker, current
smoker), socioeconomic status (level of education: primary school,
junior high school, senior high school, higher vocational school, or
university), total energy intake (kcal/day), alcohol intake (0, 0.1–4,
5–14, 15–29, $30 g/day), clothing size, and consumption of red
meat, fruit, vegetables, and fiber (g/day).
To assess how measures of anthropometry and physical activity
were associated with the extent of promoter methylation in the
CRC tumors, we used the aforementioned methylation index to
categorize cases into one of three groups: ‘0–1 genes methylated’,
‘2–3 genes methylated’, or ‘4–7 genes methylated’. Of the 734
cases, 556 had sufficient information to be classified into one of the
three categories. Models including anthropometric variables were
adjusted for age, sex, and mutually adjusted for other anthropo-
metric variables as previously described, and the model for
physical activity was adjusted for age and sex.
Tests for heterogeneity were done to evaluate differences
between subtypes of tumors (e.g., CIMP vs. non–CIMP) using the
competing risks procedure in STATA. However, the SE for the
difference of the log–hazard ratios from this procedure assumes
independence of both estimated hazard ratios, which would
overestimate that SE and thus overestimate the P values for their
difference. Therefore, these P values and the associated confidence
intervals were estimated based on a bootstrapping method that
was developed for the case-cohort design, as described previously
[53]. Each bootstrap analysis was based on 1000 replications.
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